Arnaud CD. An integrated view of the role of the endocrine system in the genesis of the osteoporosis associated with aging. Osteoporos Int. 1993;3 Suppl.1:37–9.

Article  PubMed  Google Scholar 

Zheng SX, Vrindts Y, Lopez M, De Groote D, Zangerle PF, Collette J, et al. Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas. 1997;26:63–71.

Article  CAS  PubMed  Google Scholar 

Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 1995;136:3054–61.

Article  CAS  PubMed  Google Scholar 

Qiu J, Lu C, Zhang L, Zhou X, Zou H. Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors. Clin Rheumatol. 2022;41:2685–93.

Article  PubMed  Google Scholar 

Buchanan WW, Samuels BM, Jasani MK, Anderson JA, O’Brien WM, Boyle JA, et al. Do oral corticosteroids cause osteoporosis in rheumatoid arthritis? Ann Rheum Dis. 1970;29:560–1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madretsma GS, Dijk AP, Tak CJ, Wilson JH, Zijlstra FJ. Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process. Mediat Inflamm. 1996;5:100–3.

Article  CAS  Google Scholar 

Huang YS, Das UN, Horrobin DF. Effect of dexamethasone on the distribution of essential fatty acids in plasma and liver phospholipids. IRCS Med Sci. 1986;14:10–181.

Google Scholar 

Manjari V, Das UN. Effect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damage. Prostaglandins Leukot Essent Fat Acids. 2000;62:85–96.

Article  CAS  Google Scholar 

Marra CA, de Alaniz MJ, Brenner RR. Modulation of delta 6 and delta 5 rat liver microsomal desaturase activities by dexamethasone-induced factor. Biochim Biophys Acta. 1986;879:388–93.

Article  CAS  PubMed  Google Scholar 

Marra CA, de Alaniz MJ, Brenner RR. Effect of various steroids on the biosynthesis of arachidonic acid in isolated hepatocytes and HTC cells. Lipids. 1988;23:1053–8.

Article  CAS  PubMed  Google Scholar 

Das UN. Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases. Eur J Clin Nutr. 2022. https://doi.org/10.1038/s41430-022-01173-8.

Das UN. Essential fatty acids and their metabolites in the pathobiology of inflammation and its resolution. Biomolecules. 2021;11:1873.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayer K, Schmidt R, Muhly-Reinholz M, Bögeholz T, Gokorsch S, Grimminger F, et al. In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFalpha impact of omega-3 versus omega-6 fatty acids. J Lipid Res. 2002;43:944–51.

Article  CAS  PubMed  Google Scholar 

Gundala NKV, Naidu VGM, Das UN. Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo. Nutrition. 2017;35:61–80.

Article  CAS  PubMed  Google Scholar 

Bathina S, Gundala NKV, Rhenghachar P, Polavarapu S, Hari AD, Sadananda M, et al. Resolvin D1 ameliorates nicotinamide-streptozotocin-induced type 2 diabetes mellitus by its anti-inflammatory action and modulating PI3K/Akt/mTOR pathway in the brain. Arch Med Res. 2020;51:492–503.

Article  CAS  PubMed  Google Scholar 

Rengachar P, Polavarapu S, Das UN. Insights in diabetes: molecular mechanisms-Protectin DX, an anti-inflammatory and a stimulator of inflammation resolution metabolite of docosahexaenoic acid, protects against the development of streptozotocin-induced type 1 and type 2 diabetes mellitus in male Swiss albino mice. Front Endocrinol. 2023;13:1053879.

Article  Google Scholar 

Russell R, Gori I, Pellegrini C, Kumar R, Achtari C, Canny GO. Lipoxin A4 is a novel estrogen receptor modulator. FASEB J. 2011;25:4326–37.

Article  CAS  PubMed  Google Scholar 

Kumar R, Clerc AC, Gori I, Russell R, Pellegrini C, Govender L, et al. Lipoxin A4 prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E2 production and estrogen signaling. PLoS ONE. 2014;9:e89742.

Article  PubMed  PubMed Central  Google Scholar 

Das UN. Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition. 2002;18:178–88.

Article  CAS  PubMed  Google Scholar 

Liu XH, Kirschenbaum A, Yao S, Levine AC. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-B (RANK) ligand/RANK system. Endocrinology. 2005;146:1991–8.

Article  CAS  PubMed  Google Scholar 

Das UN. Bioactive lipids as modulators of immune check point inhibitors. Med Hypotheses. 2020;135:109473.

Article  CAS  PubMed  Google Scholar 

Das UN. Can bioactive lipid(s) augment anti-cancer action of immunotherapy and prevent cytokine storm? Arch Med Res. 2019;50:342–9.

Article  CAS  PubMed  Google Scholar 

Liu C, Guan H, Cai C, Li F, Xiao J. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss. Exp Cell Res. 2017;352:293–303.

Article  CAS  PubMed  Google Scholar 

Yang Y, Wang Y, Kong Y, Zhang X, Bai L. The effects of different frequency treadmill exercise on lipoxin A4 and articular cartilage degeneration in an experimental model of monosodium iodoacetate-induced osteoarthritis in rats. PLoS ONE. 2017;12:e0179162.

Article  PubMed  PubMed Central  Google Scholar 

Wimalawansa SJ, Chapa MT, Yallampalli C, Zhang R, Simmons DJ. Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. Bone. 1997;21:275–80.

Article  CAS  PubMed  Google Scholar 

Wimalawansa SJ, De Marco G, Gangula P, Yallampalli C. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone. 1996;18:301–4.

Article  CAS  PubMed  Google Scholar 

Pennisi P, D’Alcamo MA, Leonetti C, Clementi A, Cutuli VM, Riccobene S, et al. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model. J Bone Miner Metab. 2005;23:134–9.

Article  CAS  PubMed  Google Scholar 

Roncero-Martín R, Aliaga I, Moran JM, Puerto-Parejo LM, Rey-Sánchez P, de la Luz Canal-Macías M, et al. Plasma fatty acids and quantitative ultrasound, DXA and pQCT derived parameters in postmenopausal Spanish women. Nutrients. 2021;13:1454.

Article  PubMed  PubMed Central  Google Scholar 

Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis. Osteoporos Int 2013;24:1647–61.

Article  PubMed  Google Scholar 

Coetzee M, Haag M, Joubert AM, Kruger MC. Effects of arachidonic acid, docosahexaenoic acid and prostaglandin E2 on cell proliferation and morphology of MG-63 and MC3T3-E1 osteoblast-like cells. Prostaglandins Leukot Essent Fat Acids. 2007;76:35–45.

Article  CAS  Google Scholar 

Hogstrom M, Nordström P, Nordström A. N-3 fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 study. Am J Clin Nutr 2007;85:803–7.

Article  PubMed  Google Scholar 

Virtanen JK, Mozaffarian D, Willett WC, Feskanich D. Dietary intake of polyunsaturated fatty acids and risk of hip fracture in men and women. Osteoporos Int 2012;23:2615–24.

Article  CAS  PubMed